|
1
|
Haggar FA and Boushey RP: Colorectal
cancer epidemiology: incidence, mortality, survival, and risk
factors. Clin Colon Rectal Surg. 22:191–197. 2009.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Siegel RL, Miller KD, Goding Sauer A,
Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA and Jemal
A: Colorectal cancer statistics, 2020. CA Cancer J Clin.
70:145–164. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Mojtahedi Z, Mohmedi M, Rahimifar S,
Erfani N, Hosseini SV and Ghaderi A: Programmed death-1 gene
polymorphism (PD-1.5 C/T) is associated with colon cancer. Gene.
508:229–232. 2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zhang Y, Wu Y, Gong ZY, Ye HD, Zhao XK, Li
JY, Zhang XM, Li S, Zhu W, Wang M, et al: Distinguishing rectal
cancer from colon cancer based on the support vector machine method
and RNA-sequencing data. Curr Med Sci. 41:368–374. 2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Labianca R, Beretta GD, Kildani B, Milesi
L, Merlin F, Mosconi S, Pessi MA, Prochilo T, Quadri A, Gatta G, et
al: Colon cancer. Crit Rev Oncol Hematol. 74:106–133.
2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Rosen AW, Degett TH and Gögenur I:
Individualized treatment of colon cancer. Ugeskr Laeger.
178(V11150916)2016.PubMed/NCBI(In Danish).
|
|
9
|
Bellizzi A, Sebastian S, Ceglia P,
Centonze M, Divella R, Manzillo EF, Azzariti A, Silvestris N,
Montemurro S, Caliandro C, et al: Co-expression of CD133(+)/CD44(+)
in human colon cancer and liver metastasis. J Cell Physiol.
228:408–415. 2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
van Hemert MJ, Steensma HY and van Heusden
GP: 14-3-3 proteins: Key regulators of cell division, signalling
and apoptosis. Bioessays. 23:936–946. 2001.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Mackintosh C: Dynamic interactions between
14-3-3 proteins and phosphoproteins regulate diverse cellular
processes. Biochem J. 381:329–342. 2004.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hua Y, Wang H, Wang H, Wu X, Yang L, Wang
C, Li X, Jin Y, Li M, Wang L, et al: Circular RNA Circ_0006282
promotes cell proliferation and metastasis in gastric cancer by
regulating microRNA-144-5p/tyrosine 3-monooxygenase/tryptophan
5-monooxygenase activation protein β axis. Cancer Manag Res.
13:815–827. 2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zhang X, Zhang Q, Zhang K, Wang F, Qiao X
and Cui J: Circ SMARCA5 inhibited tumor metastasis by interacting
with SND1 and downregulating the YWHAB gene in cervical cancer.
Cell Transplant. 30(963689720983786)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ahluwalia P, Mondal AK, Bloomer C, Fulzele
S, Jones K, Ananth S, Gahlay GK, Heneidi S, Rojiani AM, Kota V and
Kolhe R: Identification and clinical validation of a novel 4
gene-signature with prognostic utility in colorectal cancer. Int J
Mol Sci. 20(3818)2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Gao J, Zhou XL, Kong RN, Ji LM, He LL and
Zhao DB: microRNA-126 targeting PIK3R2 promotes rheumatoid
arthritis synovial fibro-blasts proliferation and resistance to
apoptosis by regulating PI3K/AKT pathway. Exp Mol Pathol.
100:192–198. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Xiao J, Lin HY, Zhu YY, Zhu YP and Chen
LW: MiR-126 regulates proliferation and invasion in the bladder
cancer BLS cell line by targeting the PIK3R2-mediated PI3K/Akt
signaling pathway. Onco Targets Ther. 9:5181–5193. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Xi T, Jin F, Zhu Y, Wang J, Tang L, Wang
Y, Liebeskind DS and He Z: MicroRNA-126-3p attenuates blood-brain
barrier disruption, cerebral edema and neuronal injury following
intracerebral hemorrhage by regulating PIK3R2 and Akt. Biochem
Biophys Res Commun. 494:144–151. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Dornan GL and Burke JE: Molecular
mechanisms of human disease mediated by oncogenic and primary
immunodeficiency mutations in class IA phosphoinositide 3-kinases.
Front Immunol. 9(575)2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Cortés I, Sánchez-Ruíz J, Zuluaga S,
Calvanese V, Marqués M, Hernández C, Rivera T, Kremer L,
González-García A and Carrera AC: p85β phosphoinositide 3-kinase
subunit regulates tumor progression. Proc Natl Acad Sci USA.
109:11318–11323. 2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Yaghoubi A, Khazaei M, Avan A, Hasanian SM
and Soleimanpour S: The bacterial instrument as a promising therapy
for colon cancer. Int J Colorectal Dis. 35:595–606. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Gao F, Xu T, Wang X, Zhong S, Chen S,
Zhang M, Zhang X, Shen Y, Wang X, Xu C and Shen Z: CIP2A mediates
fibronectin-induced bladder cancer cell proliferation by
stabilizing beta-catenin. J Exp Clin Cancer Res.
36(70)2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kaczanowski S: Apoptosis: its origin,
history, maintenance and the medical implications for cancer and
aging. Phys Biol. 13(031001)2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Pistritto G, Trisciuoglio D, Ceci C,
Garufi A and D'Orazi G: Apoptosis as anticancer mechanism: function
and dysfunction of its modulators and targeted therapeutic
strategies. Aging (Albany NY). 8:603–619. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ahmad I, Fakhri S, Khan H, Jeandet P,
Aschner M and Yu ZL: Targeting cell cycle by beta-carboline
alkaloids in vitro: Novel therapeutic prospects for the treatment
of cancer. Chem Biol Interact. 330(109229)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Manchado E, Guillamot M and Malumbres M:
Killing cells by targeting mitosis. Cell Death Differ. 19:369–377.
2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
de Castro Sant' Anna C, Junior AGF, Soares
P, Tuji F, Paschoal E, Chaves LC and Burbano RR: Molecular biology
as a tool for the treatment of cancer. Clin Exp Med. 18:457–464.
2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Herzig DO and Tsikitis VL: Molecular
markers for colon diagnosis, prognosis and targeted therapy. J Surg
Oncol. 111:96–102. 2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Xu C, Du Z, Ren S, Liang X and Li H:
MiR-129-5p sensitization of lung cancer cells to etoposide-induced
apoptosis by reducing YWHAB. J Cancer. 11:858–866. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Singh AN and Sharma N: Quantitative
SWATH-based proteomic profiling for identification of
mechanism-driven diagnostic biomarkers conferring in the
progression of metastatic prostate cancer. Front Oncol.
10(493)2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Liu Y, Qin Z, Cai L, Zou L, Zhao J and
Zhong F: Selection of internal references for qRT-PCR assays of
human hepatocellular carcinoma cell lines. Biosci Rep.
37:2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Huang KC, Huang TW, Chuang PY, Yang TY and
Chang SF: Zoledronate induces cell cycle arrest and differentiation
by upregulating p21 in mouse MC3T3-E1 preosteoblasts. Int J Med
Sci. 16:751–756. 2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Mansilla SF, de la Vega MB, Calzetta NL,
Siri SO and Gottifredi V: CDK-independent and PCNA-dependent
functions of p21 in DNA replication. Genes (Basel).
11(593)2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Rao L, Mak VCY, Zhou Y, Zhang D, Li X,
Fung CCY, Sharma R, Gu C, Lu Y, Tipoe GL, et al: p85β regulates
autophagic degradation of AXL to activate oncogenic signaling. Nat
Commun. 11(2291)2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Song L, Xie X, Yu S, Peng F and Peng L:
MicroRNA126 inhibits proliferation and metastasis by targeting
pik3r2 in prostate cancer. Mol Med Rep. 13:1204–1210.
2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Lin J, Zeng C, Zhang J, Song Z, Qi N, Liu
X, Zhang Z, Li A and Chen F: EFNA4 promotes cell proliferation and
tumor metastasis in hepatocellular carcinoma through a
PIK3R2/GSK3β/β-catenin positive feedback loop. Mol Ther Nucleic
Acids. 25:328–341. 2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Noorolyai S, Shajari N, Baghbani E,
Sadreddini S and Baradaran B: The relation between PI3K/AKT
signalling pathway and cancer. Gene. 698:120–128. 2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Yu JS and Cui W: Proliferation, survival
and metabolism: The role of PI3K/AKT/mTOR signalling in
pluripotency and cell fate determination. Development.
143:3050–3060. 2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Zhang J, Zhang Z, Zhang DY, Zhu J, Zhang T
and Wang C: microRNA 126 inhibits the transition of endothelial
progenitor cells to mesenchymal cells via the PIK3R2-PI3K/Akt
signalling pathway. PLoS One. 8(e83294)2013.PubMed/NCBI View Article : Google Scholar
|
